Skip to main content
. 2016 May 16;12(3):325–337. doi: 10.2217/whe-2016-0018

Figure 2.

Figure 2.

Mean (standard error) change in satisfying sexual events/month: female sexual function index total score: and female sexual distress scale-desire/arousal/orgasm total score from double-blind baseline to end of study in all patients and in patients with hypoactive sexual desire disorder as their primary or sole female sexual dysfunction diagnosis (modified intent-to-treat population) (see facing page). Van Elteren test stratified by diagnosis.

*p < 0.05 versus placebo.

**p < 0.01 versus placebo.

***p < 0.001 versus placebo.

BMT: Bremelanotide; FSDS-DAO: Female sexual distress scale-desire/arousal/orgasm; FSFI: Female sexual function index; HSDD: Hypoactive sexual desire disorder; SE: Standard error; SSE: Satisfying sexual event.